Jean-Marc Bellemin
Director of Finance/CFO presso IOVANCE BIOTHERAPEUTICS, INC.
Patrimonio netto: 868 096 $ in data 31/03/2024
Profilo
Jean-Marc Bellemin ricopre la posizione di CFO & Principal Accounting Officer di Iovance Biotherapeutics, Inc. In passato è stato Chief Financial Officer & Executive Vice President di Gritstone Oncology, Inc. e Senior Vice President-Business Solutions di Actelion Pharmaceuticals US, Inc. Il sig. Bellemin ha conseguito una laurea presso l'Universit Paris Dauphine-PSL, una laurea presso l'Universit Paris II Panthon Assas e un MBA presso la ESSEC Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 01/03/2024 | 58 576 ( 0.02% ) | 868 096 $ | 31/03/2024 |
Posizioni attive di Jean-Marc Bellemin
| Società | Posizione | Inizio |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Director of Finance/CFO | 14/12/2020 |
Precedenti posizioni note di Jean-Marc Bellemin
| Società | Posizione | Fine |
|---|---|---|
| GRITSTONE BIO, INC. | Director of Finance/CFO | 11/12/2020 |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01/12/2017 |
Formazione di Jean-Marc Bellemin
| Université Paris Dauphine-PSL | Undergraduate Degree |
| ESSEC Business School | Masters Business Admin |
| Université Paris II Panthéon Assas | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| GRITSTONE BIO, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
- Borsa valori
- Insiders
- Jean-Marc Bellemin
